Alembic Pharmaceuticals Limited (Aplltd) (NSE: APLLTD, BSE: 533573) is a Vadodara, Gujarat-based company in the Non-Prescription Drugs industry. With a market capitalisation of ₹15,518 Cr, it ranks #438 by market cap among the 6,137 Indian listed companies on FinBizNet, and #2 of 9 in Non-Prescription Drugs. At ₹760.10 (as of 25 Oct 2026), the share price is 23.8% below its 52-week high of ₹998.00 and 19.6% above its 52-week low of ₹635.80. The share price is down 18.6% over one year and down 4.7% over three months.
| Current Price | ₹760.10 |
|---|---|
| Market Cap | ₹15,518 Cr |
| NSE Symbol | APLLTD |
| BSE Code | 533573 |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Non-Prescription Drugs |
| P/E Ratio | 23 |
| Return on Equity | 12.36% |
| Return on Assets | 6.03% |
| 52-Week Range | ₹635.80 – ₹998.00 |
| 1-Year Price Change | -18.6% |
| 3-Month Price Change | -4.7% |
| Beta (1Y) | 0.28 |
| Dividend Yield | 1.52% |
| Headquarters | Vadodara, Gujarat |
| Website | alembicpharmaceuticals.com |
| Revenue | ₹2,150 Cr |
|---|---|
| Net Profit | ₹172 Cr |
| Net Margin | 8.0% |
| EPS (Basic) | ₹8.80 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.
1. Pharmaceuticals Business-This segment develops, manufactures, and markets pharmaceutical products.
1. Pharmaceuticals-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | ₹43,456 Cr | 40.8 | 48.91% | ₹938 Cr | -11.7% |
| Alembic Pharmaceuticals Limited (Aplltd) | ₹15,518 Cr | 23 | 12.36% | ₹2,150 Cr | -18.6% |
| Bliss Gvs Pharma Ltd. | ₹7,005 Cr | 52.5 | 11.60% | ₹286 Cr | +308.7% |
| Zota Health Care Ltd | ₹4,881 Cr | -60.3 | -16.05% | ₹174 Cr | -17.5% |
| Amrutanjan Health Care Ltd. | ₹1,482 Cr | 25.6 | 16.62% | ₹103 Cr | -30.3% |
| Jenburkt Pharmaceuticals Ltd. | ₹404 Cr | 11.7 | 18.84% | — | -11.8% |
| Sat Kartar Life Limited | ₹210 Cr | 12.3 | — | — | — |
| Vista Pharmaceuticals Ltd. | ₹39 Cr | -7.9 | -10.82% | — | -37.7% |
| Welcure Drugs & Pharmaceuticals | ₹25 Cr | -5 | -5.50% | — | -75.6% |
Listed by market capitalisation. Ratios are shown for context only.
Alembic Pharmaceuticals Limited (Aplltd) is trading at ₹760.10, with a market capitalisation of ₹15,518 Cr.
Alembic Pharmaceuticals Limited (Aplltd) operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Non-Prescription Drugs).
Alembic Pharmaceuticals Limited (Aplltd) has a P/E of 23 and a return on equity of 12.36%.
Alembic Pharmaceuticals Limited (Aplltd) is listed on the NSE under the symbol APLLTD and on the BSE under the scrip code 533573.
Alembic Pharmaceuticals Limited (Aplltd)'s share price is down 18.6% over one year and down 4.7% over three months. Its 52-week range is ₹635.80 to ₹998.00.
In Q1 FY27, Alembic Pharmaceuticals Limited (Aplltd) reported revenue of ₹2,150 Cr and net profit of ₹172 Cr, with basic EPS of ₹8.8 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.